Mecasermin (rh-IGF-1) treatment for Rett Syndrome is safe and well-tolerated
The results from Boston Children's Hospital's Phase 1 human clinical trial in Rett syndrome came out today. A team of investigators successfully completed a Phase 1 clinical trial using mecasermin [recombinant human insulin-like ...
Mar 10, 2014
0
0